MEDICURE INC
MCUJFDrugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Nov 2026
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
(MC-1) Pyridoxal 5'-phosphate
Coronary Artery Bypass Graft Surgery
Pyridoxal Phosphate
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Short Tirofiban
Myocardial Infarction
(MC-1) Pyridoxal-5'-phosphate
Coronary Artery Bypass Graft Surgery
pyridoxal-5'-phosphate with and without ACE inhibitor
Diabetes Mellitus Type 2
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
(MC-1) Pyridoxal 5'-phosphate | Phase 3 | Coronary Artery Bypass Graft Surgery | - | - |
Pyridoxal Phosphate | Phase 3 | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency | - | - |
Short Tirofiban | Phase 2 | Myocardial Infarction | - | - |
(MC-1) Pyridoxal-5'-phosphate | Phase 2 | Coronary Artery Bypass Graft Surgery | - | - |
pyridoxal-5'-phosphate with and without ACE inhibitor | Phase 2 | Diabetes Mellitus Type 2 | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in MEDICURE INC's drug pipeline?→
CatalystAlert tracks 5 drug candidates in MEDICURE INC's (MCUJF) pipeline across Phase 3, Phase 2. Its lead program is (MC-1) Pyridoxal 5'-phosphate (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is MEDICURE INC's next FDA catalyst?→
MEDICURE INC's (MCUJF) next tracked catalyst is a Phase 3 expected November 15, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track MCUJF biotech catalysts?→
Add MCUJF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MEDICURE INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.